Similar articles

• [Local adverse reactions associated with parenteral administration of drugs].

  Bjånes TK. Bjånes TK. Tidsskr Nor Laegeforen. 2011 Mar 4;131(5):472-4. doi: 10.4045/tidsskr.09.1515. Tidsskr Nor Laegeforen. 2011. PMID: 21383802 Norwegian.
• [Studies of the pH of drugs administered parenterally].

  Zietkiewicz W, Kostrzewska E. Zietkiewicz W, et al. Pol Tyg Lek. 1971 Jun 21;26(25):937-9. Pol Tyg Lek. 1971. PMID: 5564508 Polish. No abstract available.
• Guidelines for the administration of commonly used intravenous drugs.

  Rapp RP, Wermeling DP, Piecoro JJ Jr. Rapp RP, et al. Drug Intell Clin Pharm. 1984 Mar;18(3):217-32. Drug Intell Clin Pharm. 1984. PMID: 6697884 No abstract available.
• Intravenous drug delivery in infants with limited i.v. access and fluid restriction.

  Zenk KE. Zenk KE. Am J Hosp Pharm. 1987 Nov;44(11):2542-5. Am J Hosp Pharm. 1987. PMID: 3120582 Review. No abstract available.
• [Prescription writing: impact of neonatal pharmacological data].

  Autret-Leca E, Jonville-Béra AP, Yavo JC. Autret-Leca E, et al. Ann Dermatol Venereol. 1999 Dec;126(12):922-6. Ann Dermatol Venereol. 1999. PMID: 10648970 Review. French. No abstract available.